Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
Author | |
---|---|
Abstract | :
To report 4-year imaging outcomes in the RAPID-axSpA (NCT01087762) study of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA), treated with certolizumab pegol (CZP). |
Year of Publication | :
2018
|
Journal | :
Annals of the rheumatic diseases
|
Date Published | :
2018
|
ISSN Number | :
0003-4967
|
URL | :
http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=29343510
|
DOI | :
10.1136/annrheumdis-2017-212377
|
Short Title | :
Ann Rheum Dis
|
Download citation |